Siderowf A - Search Results

1

¹⁸ F-flortaucipir tau positron emission tomography distinguishes established progressive supranuclear palsy from controls and Parkinson disease: A multicenter study.

Schonhaut DR, McMillan CT, Spina S, Dickerson BC, Siderowf A, Devous MD Sr, Tsai R, Winer J, Russell DS, Litvan I, Roberson ED, Seeley WW, Grinberg LT, Kramer JH, Miller BL, Pressman P, Nasrallah I, Baker SL, Gomperts SN, Johnson KA, Grossman M, Jagust WJ, Boxer AL, Rabinovici GD. Schonhaut DR, et al. Among authors: siderowf a. Ann Neurol. 2017 Oct;82(4):622-634. doi: 10.1002/ana.25060. Ann Neurol. 2017. PMID: 28980714 Free PMC article.

2

Systemic non-Hodgkin's lymphoma manifesting as neurogenic respiratory failure.

Wolfe GI, Raps EC, Galetta SL, Siderowf AD, Brown MJ, Bird SJ. Wolfe GI, et al. Among authors: siderowf ad. Neurology. 1995 Mar;45(3 Pt 1):589-90. doi: 10.1212/wnl.45.3.589. Neurology. 1995. PMID: 7898725 No abstract available.

3

Central neurogenic hyperventilation in an awake patient with a pontine glioma.

Siderowf AD, Balcer LJ, Kenyon LC, Nei M, Raps EC, Galetta SL. Siderowf AD, et al. Neurology. 1996 Apr;46(4):1160-2. doi: 10.1212/wnl.46.4.1160. Neurology. 1996. PMID: 8780113

4

Posey and Spiller and progressive supranuclear palsy: an incorrect attribution.

Siderowf AD, Galetta SL, Hurtig HI, Liu GT. Siderowf AD, et al. Mov Disord. 1998 Jan;13(1):170-4. doi: 10.1002/mds.870130133. Mov Disord. 1998. PMID: 9452346

5

Preference-based quality-of-life in patients with Parkinson's disease.

Siderowf A, Ravina B, Glick HA. Siderowf A, et al. Neurology. 2002 Jul 9;59(1):103-8. doi: 10.1212/wnl.59.1.103. Neurology. 2002. PMID: 12105315

6

Multiple pathologies in a patient with a progressive neurodegenerative syndrome.

Liang TW, Forman MS, Duda JE, McCluskey L, Trojanowski JQ, Siderowf A. Liang TW, et al. Among authors: siderowf a. J Neurol Neurosurg Psychiatry. 2005 Feb;76(2):252-5. doi: 10.1136/jnnp.2004.039479. J Neurol Neurosurg Psychiatry. 2005. PMID: 15654043 Free PMC article.

7

[99mTc]TRODAT-1 SPECT imaging correlates with odor identification in early Parkinson disease.

Siderowf A, Newberg A, Chou KL, Lloyd M, Colcher A, Hurtig HI, Stern MB, Doty RL, Mozley PD, Wintering N, Duda JE, Weintraub D, Moberg PJ. Siderowf A, et al. Neurology. 2005 May 24;64(10):1716-20. doi: 10.1212/01.WNL.0000161874.52302.5D. Neurology. 2005. PMID: 15911797

8

Preclinical diagnosis of Parkinson's disease: are we there yet?

Siderowf A, Stern MB. Siderowf A, et al. Curr Neurol Neurosci Rep. 2006 Jul;6(4):295-301. doi: 10.1007/s11910-006-0021-z. Curr Neurol Neurosci Rep. 2006. PMID: 16822349 Review.

9

F2 isoprostane levels in plasma and urine do not support increased lipid peroxidation in cognitively impaired Parkinson disease patients.

Connolly J, Siderowf A, Clark CM, Mu D, Pratico D. Connolly J, et al. Among authors: siderowf a. Cogn Behav Neurol. 2008 Jun;21(2):83-6. doi: 10.1097/WNN.0b013e31817995e7. Cogn Behav Neurol. 2008. PMID: 18541983

10

Treatment disparities in Parkinson's disease.

Dahodwala N, Xie M, Noll E, Siderowf A, Mandell DS. Dahodwala N, et al. Among authors: siderowf a. Ann Neurol. 2009 Aug;66(2):142-5. doi: 10.1002/ana.21774. Ann Neurol. 2009. PMID: 19743462 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

267 results

Search Page

Filters